Recent research has helped further define genetic heritability for pediatric autoimmune diseases. In an interview, Dr. Hakon Hakanarson discusses how understanding common genetic factors can help develop risk prediction and treatments for such diseases as juvenile idiopathic arthritis, lupus and celiac disease…
The FDA recently approved a form of naloxone hydrochloride in a nasal spray that will help counter opioid overdoses. The FDA also approved an ibuprofen injection as an adjunct to opioids for use in children 6 months and older…
NEW YORK (Reuters Health)—Exposure to probiotics in the first few weeks of life is associated with a reduced risk of islet autoimmunity, according to results from the TEDDY study. “Early supplementation of probiotics may be important but we need more research on this,” Dr. Ulla Uusitalo from University of South Florida in Tampa told Reuters…
The ACR member Dr. Marilyn G. Punaro is first pediatric rheumatologist to earn the Patricia & William L. Watson Jr., MD, award
A pediatric patient with juvenile rheumatoid arthritis shares her perspective on living with the disease, importance of pediatric rheumatology care
New data examine infliximab as a treatment option, and updated diagnostic criteria aids physicians in recognizing KD and detecting cardiac involvement in patients
Conference to feature practice management tips and latest findings in clinical, translational, and basic research on treating rheumatic diseases in children
A robust workforce, flourishing clinical trials, broad patient registries, and consensus treatment protocols contribute to improvements for the subspecialty
ARHP members are honored with awards for research, education, advocacy, and patient care in rheumatology
Annual conference to be held April 3–6 in Orlando, Fla.